Health Condition 1: null- alopecia, atrophic acne scars, striae
Conditions
Interventions
Intervention1: autologus platelet rich plasma(PRP)
dose: 4 ml( 9 part PRP with 1 part sterile calcium gluconate)
frequency: once monthly
route of administration: intradermal: autologus platelet rich
Sponsors
Gujarat Cancer Society Medical college hospital and research centre
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients between ages of 18 to 70 years. 2. Patients with androgenic alopecia or scaring alopecia who are not taking any other treatment. 3. Patients with atrophic scars >1 in no. and not taking any other treatment. 4. Patients with straie >1 in no. 5. Otherwise healthy patients. 6. Non-pregnant, non-lactating women
Exclusion criteria
Exclusion criteria: 1. Patients below age of 18 or above the age of 70 yr. 2. Patients who were on oral isotretinoin in last 6 months. 3. Patients who underwent any surgical modality of treatment in last 2 month. 4. Patients who have history of keloid formation or koebnerization for vitiligo. 5. Patients with atrophic scars or striae 6. Patients who are on oral immunosuppressive drugs. 7. Patients having history of any systemic diseases like- renal disease, liver disease, diabetes, tuberculosis, HIV etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| alopecia primary outcome: increase in hair density, increase hair growth. acne scar primary outcome:rejuvenation of acne scars,decrease depth of scars striae:decrease in thickness and length, decrease erythemaTimepoint: every month for six months | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse events, minimum time duration for starting and maximum effects.Timepoint: every month for six months | — |
Countries
India
Contacts
Public ContactDr Jigna Padhiyar
GCS Medical College, hospital and research centre
Outcome results
None listed